Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
Alina KirichenkoDmitry KireevAlexey LopatukhinAnastasia MurzakovaIlya LapovokDaria SaleevaNatalya LadnayaAgigat GadirovaSabina IbrahimovaAygun SafarovaTrdat GrigoryanArshak PetrosyanTatevik SarhatyanElena GasichAnastasia BunasIryna GlinskayaPavel YurovskyRustam NurovAlijon SolievLaylo IsmatovaErkin MusabaevEvgeniya KazakovaVisola RakhimovaVadim PokrovskyPublished in: PloS one (2022)
Our study demonstrated different PDR prevalence rates and DR dynamics in six EECA countries, with worrying levels of PDR in Tajikistan and Belarus, where prevalence exceeded the 10% threshold recommended by the WHO for immediate public health action. Because DR testing for clinical purposes is not common in EECA, it is currently extremely important to conduct surveillance of HIV DR in EECA due to the increased ART coverage in this region.